To learn more about this topic, including the diagnosis and interdisciplinary management of MacTel, go to ...

Schulz: When shaping the International Glaucoma Symposium 2026 agenda, we intentionally built a balanced program that reflects both core clinical practice and the rapid evolution of technology in ...

Implement targeted therapies in treatment plans to eradicate Demodex and improve outcomes in patients with Demodex ...

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

The FDA endorsed a ≥2-point reduction on a visual analogue scale for pain as a clinically meaningful endpoint for urcosimod ...

The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...

Belite Bio completes enrollment in phase 2/3 DRAGON II clinical trial evaluating tinlarebant for the treatment of Stargardt ...

Opus Genetics is conducting a trial for OPGx-MERTK gene therapy in Abu Dhabi, targeting MERTK-related retinitis pigmentosa using AAV-based delivery. The trial is a collaboration with Cleveland Clinic ...

The study highlights the importance of shear-thinning behavior in artificial tears, crucial for mimicking natural tear properties and ensuring ocular surface protection. Hyaluronic acid's ...

Myra Vision has treated the first patient in its ADAPT clinical study evaluating the Calibreye TGT Surgical System in ...

CBT-004 is a novel, preservative-free ophthalmic solution targeting VEGF and PDGF receptors to treat vascularized pinguecula. Phase 2 trial results showed significant improvements in conjunctival ...

Retinal imaging during ROP screening can predict bronchopulmonary dysplasia and pulmonary hypertension in preterm infants, ...